Literature DB >> 2841376

Albumin in monocyte function assays. Differential stimulation of superoxide or arachidonate release by calcium ionophores.

T Hoffman1, E F Lizzio.   

Abstract

Peripheral blood monocytes release superoxide (O2-) and arachidonic acid (AA) when stimulated with 12-O-tetradecanoate phorbol-13-acetate (TPA) or calcium ionophores (A23187 or ionomycin). In vitro assays of AA or O2- release performed in the presence of albumin failed to detect superoxide production when ionophore was used as the stimulating agent. Raising the concentration of ionophore or reducing the BSA concentration balanced one another in terms of detection of superoxide release. Binding of ionophore by albumin, which reduced the effective concentration of the stimulating agent, most likely accounted for this effect, but a small component could be attributed to calcium binding by albumin as well. These results indicate differing susceptibilities of monocyte functions to stimulation by increased intracellular Ca2+. Under strictly defined conditions, superoxide and arachidonate release may be assayed simultaneously. Binding of ionophores (and, by analogy, other agents) to albumin must be taken into account when determining stimulating doses for use in monocyte function assays.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2841376     DOI: 10.1016/0022-1759(88)90026-9

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  2 in total

1.  Stimulation of human monocytes by anti-CD3 monoclonal antibody: induction of inflammatory mediator release via immobilization of Fc receptor by adsorbed immunoglobulin and T-lymphocytes.

Authors:  T Hoffman; A K Tripathi; Y L Lee; E F Lizzio; E Bonvini
Journal:  Inflammation       Date:  1992-12       Impact factor: 4.092

2.  Serum and Serum Albumin Inhibit in vitro Formation of Neutrophil Extracellular Traps (NETs).

Authors:  Elsa Neubert; Susanne N Senger-Sander; Veit S Manzke; Julia Busse; Elena Polo; Sophie E F Scheidmann; Michael P Schön; Sebastian Kruss; Luise Erpenbeck
Journal:  Front Immunol       Date:  2019-01-24       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.